164 related articles for article (PubMed ID: 6133979)
21. Levalbuterol and racemic albuterol: are there therapeutic differences?
Ahrens R; Weinberger M
J Allergy Clin Immunol; 2001 Nov; 108(5):681-4. PubMed ID: 11692088
[No Abstract] [Full Text] [Related]
22. Asthma. Bronchodilators: new developments.
Tattersfield AE
Br Med Bull; 1992 Jan; 48(1):190-204. PubMed ID: 1352168
[TBL] [Abstract][Full Text] [Related]
23. [Effectiveness of berotek in bronchial asthma].
Molotkov VN
Klin Med (Mosk); 1980 Apr; 58(4):40-3. PubMed ID: 6991799
[No Abstract] [Full Text] [Related]
24. [Increased asthma fatality in chronic administration of beta agonists?].
Geisler LS
Dtsch Med Wochenschr; 1993 Feb; 118(6):206-7. PubMed ID: 8094666
[No Abstract] [Full Text] [Related]
25. New developments in bronchodilator therapy.
Nelson HS
Curr Opin Pulm Med; 1996 Jan; 2(1):35-9. PubMed ID: 9363113
[TBL] [Abstract][Full Text] [Related]
26. Risk of severe life threatening asthma.
Barnes NC; Kuitert LM
Thorax; 1996 Nov; 51(11):1073. PubMed ID: 8958886
[No Abstract] [Full Text] [Related]
27. Epidemiologic studies of beta agonists and asthma deaths.
Pearce N; Hensley MJ
Epidemiol Rev; 1998; 20(2):173-86. PubMed ID: 9919437
[No Abstract] [Full Text] [Related]
28. [Beta 2 stimulants in the therapy of childhood asthma].
Corrias A; Rossi G; Corona GB; Corda R
Pediatr Med Chir; 1987; 9(5):577-9. PubMed ID: 2894642
[TBL] [Abstract][Full Text] [Related]
29. Beta-agonists, beta-blockers and obstructive airway disease.
Madalena Esteves M
Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):375-9. PubMed ID: 16528900
[No Abstract] [Full Text] [Related]
30. [Fetal arrhythmia--a complication of betamimetic tocolysis?].
Zalányi S; Kovács L; Kertész E
Orv Hetil; 1980 Oct; 121(43):2652-4. PubMed ID: 6111062
[No Abstract] [Full Text] [Related]
31. [Beta 2 agonists in asthma therapy should be reevaluated--concerning the dosage].
Larsson K
Lakartidningen; 1991 Oct; 88(44):3643-5. PubMed ID: 1682539
[No Abstract] [Full Text] [Related]
32. Adrenergic bronchodilators and potassium.
Chest; 1987 May; 91(5):794-5. PubMed ID: 2882958
[No Abstract] [Full Text] [Related]
33. [New developments in predicting the arrhythmogenic effect of beta-adrenomimetics in chronic obstructive lung diseases].
Andrianov VP; Boĭtsov SA; Kuchmin AN; Tishchenko OL; Nedoshivin KIu
Voen Med Zh; 1996 Nov; 317(11):34-6. PubMed ID: 9036628
[No Abstract] [Full Text] [Related]
34. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
Ulmer WT; Scholz HJ; Baines A
Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
[TBL] [Abstract][Full Text] [Related]
35. Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma.
Hui KP
Singapore Med J; 1994 Jun; 35(3):237-9. PubMed ID: 7997893
[TBL] [Abstract][Full Text] [Related]
36. [Model of adrenergic-cholinolytic combination overdosing in reversible bronchial obstruction--phenoterol with ipratropium].
Vondra V; Holub M; Tomíska F
Cas Lek Cesk; 1982 Jun; 121(25):779-82. PubMed ID: 6214310
[No Abstract] [Full Text] [Related]
37. [Cardiac tolerance of a beta-2-sympathomimetic spray: fenoterol. Apropos of 37 patients followed using a Holter monitor during a brief treatment protocol].
Escamilla R; Longhi R; Miguères J; Jover A; Krempf M; Massabuau P; Bonhoure JP
Rev Mal Respir; 1985; 2(4):239-44. PubMed ID: 2418475
[TBL] [Abstract][Full Text] [Related]
38. [Adrenergic broncholytic agents. Different causes and symptoms of adverse effects].
Vale JR
Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2442-3. PubMed ID: 4144336
[No Abstract] [Full Text] [Related]
39. [Side effects of berotek].
Demchuk ES; Demchuk VM
Vrach Delo; 1982 Sep; (9):90-1. PubMed ID: 7179924
[No Abstract] [Full Text] [Related]
40. [The evaluation of the efficacy and safety of dosed aerosols of ditek, berotek and bicromat].
Tsoĭ AN; Kukes VG; Gavrilenko LN; Sadovnikova SF
Ter Arkh; 1994; 66(3):24-8. PubMed ID: 8202845
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
